Quick Answer
Akebia Therapeutics, Inc. reported Total Assets of $376.56 million for fiscal year 2025.
Akebia Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $376.56M | +70.6% |
| 2024 | $220.67M | -8.7% |
| 2023 | $241.70M | -32.1% |
| 2022 | $356.05M | -32.3% |
| 2021 | $525.55M | -18.4% |
| 2020 | $644.14M | -16.5% |
| 2019 | $771.20M | -22.6% |
| 2018 | $996.54M | +173.6% |
| 2017 | $364.25M | +21.3% |
| 2016 | $300.22M | +110.0% |
| 2015 | $142.94M | +28.8% |
| 2014 | $111.00M | +220.2% |
| 2013 | $34.66M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $364.15M | +75.8% | +5.4% |
| June 30, 2025 | $345.60M | +56.9% | +11.4% |
| March 31, 2025 | $310.19M | +37.6% | +40.6% |
| December 31, 2024 | $220.67M | -8.7% | +6.5% |
| September 30, 2024 | $207.14M | -11.9% | -5.9% |
| June 30, 2024 | $220.20M | -13.2% | -2.3% |
| March 31, 2024 | $225.48M | -19.7% | -6.7% |
| December 31, 2023 | $241.70M | -32.1% | +2.9% |
- Akebia Therapeutics, Inc. showed an increase of +70.6% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Akebia Therapeutics, Inc.’s total assets has grown by 986.3% (from $34.66 million to $376.56 million).
- The most recent figure is from Akebia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: